In this study, we examined whether targeting IL3R with SL-401 and SL-501, IL3 conjugated to diphtheria toxin, could eradicate CML stem cells. Full Abstract While imatinib and other tyrosine kinase inhibitors (TKIs) demonstrate high efficacy in the treatment of chronic myeloid leukemia (CML), ...